Automated description from the Alliance of Genome Resources
Predicted to have phosphatidylinositol 3-kinase catalytic subunit binding activity and serine-type endopeptidase activity. Involved in negative regulation of phosphatidylinositol 3-kinase activity and negative regulation of phosphatidylinositol 3-kinase signaling. Predicted to localize to the integral component of membrane and plasma membrane. Is expressed in several structures, including brain meninges; genitourinary system; heart; lung; and oral epithelium. Orthologous to human PIK3IP1 (phosphoinositide-3-kinase interacting protein 1).